Aytu Biopharma (AYTU) Amortization - Intangibles (2015 - 2026)
Aytu Biopharma (AYTU) reported Amortization - Intangibles of $761000.0 for Q1 2026, down 17.28% year-over-year from $920000.0 in Q1 2025, and up 44.68% quarter-over-quarter from $526000.0 in Q4 2025.
Aytu Biopharma (AYTU) Amortization - Intangibles (2015 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 12 years of Amortization - Intangibles data on file, last reported at $761000.0 in Q1 2026.
- Amortization - Intangibles for Q1 2026 came in at $761000.0, down 17.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (down 27.99% YoY), and the FY2025 annual result was $3.7 million, changed 0.0% from the prior year.
- Amortization - Intangibles improved to $761000.0 in Q1 2026 per AYTU's latest filing, from $526000.0 in the prior quarter.
- Over five years, Amortization - Intangibles peaked at $1.5 million in Q1 2022 and troughed at $444000.0 in Q3 2025.
- A 5-year average of $981588.2 and a median of $921000.0 in 2024 frame the typical range for Amortization - Intangibles.
- The sharpest annual moves came in 2022 and 2025: Amortization - Intangibles gained 3.43% in 2022, then plunged 51.79% in 2025.
- A 5-year view of Amortization - Intangibles shows it stood at $1.2 million in 2022, then decreased by 23.37% to $918000.0 in 2023, then climbed by 0.33% to $921000.0 in 2024, then plunged by 42.89% to $526000.0 in 2025, then surged by 44.68% to $761000.0 in 2026.
- Business Quant data shows AYTU's Amortization - Intangibles at $761000.0 in Q1 2026, $526000.0 in Q4 2025, and $444000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Aytu Biopharma | 24.18 Mn | -2.54 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 761,000.00 |
| Dec 31, 2025 | 526,000.00 |
| Sep 30, 2025 | 444,000.00 |
| Jun 30, 2025 | 921,000.00 |
| Mar 31, 2025 | 920,000.00 |
| Dec 31, 2024 | 921,000.00 |
| Sep 30, 2024 | 921,000.00 |
| Jun 30, 2024 | 921,000.00 |
| Mar 31, 2024 | 920,000.00 |
| Dec 31, 2023 | 918,000.00 |
| Sep 30, 2023 | 924,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 1.26 Mn |